Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKRO NASDAQ:HEES NYSE:OKLO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKROAkero Therapeutics$43.77-4.1%$50.09$21.34▼$58.40$3.50B-0.241.37 million shs1.03 million shsHEESH&E Equipment Services$94.64$94.46$40.93▼$101.28$3.47B1.87614,767 shsN/AOKLOOklo$69.86-3.3%$67.75$5.35▼$85.35$10.33B0.5917.79 million shs7.77 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKROAkero Therapeutics+0.40%-5.33%-6.17%-15.42%+75.53%HEESH&E Equipment Services0.00%0.00%0.00%0.00%+111.44%OKLOOklo-1.74%-1.67%-5.59%+52.76%+1,189.59%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKROAkero Therapeutics$43.77-4.1%$50.09$21.34▼$58.40$3.50B-0.241.37 million shs1.03 million shsHEESH&E Equipment Services$94.64$94.46$40.93▼$101.28$3.47B1.87614,767 shsN/AOKLOOklo$69.86-3.3%$67.75$5.35▼$85.35$10.33B0.5917.79 million shs7.77 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKROAkero Therapeutics+0.40%-5.33%-6.17%-15.42%+75.53%HEESH&E Equipment Services0.00%0.00%0.00%0.00%+111.44%OKLOOklo-1.74%-1.67%-5.59%+52.76%+1,189.59%Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKROAkero TherapeuticsN/AN/AN/AN/A$12.82 per shareN/AHEESH&E Equipment Services$1.46B2.37$14.76 per share6.41$14.66 per share6.46OKLOOkloN/AN/AN/AN/A$4.72 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKROAkero Therapeutics-$252.06M-$2.00N/AN/AN/AN/A-15.84%-14.59%11/14/2025 (Estimated)HEESH&E Equipment Services$169.29M$2.4924.0224.58N/A9.47%25.46%5.16%N/AOKLOOklo-$73.62M-$0.42N/AN/AN/AN/A-14.80%-13.61%11/13/2025 (Estimated)Latest AKRO, HEES, and OKLO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025OKLOOklo-$0.12-$0.18-$0.06-$0.18N/AN/A8/8/2025Q2 2025AKROAkero Therapeutics-$0.97-$0.86+$0.11-$0.86N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKROAkero TherapeuticsN/AN/AN/AN/AN/AHEESH&E Equipment Services$1.101.16%N/A44.18%N/AOKLOOkloN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKROAkero Therapeutics0.0212.6612.66HEESH&E Equipment Services2.090.640.59OKLOOkloN/A71.2771.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKROAkero TherapeuticsN/AHEESH&E Equipment Services84.08%OKLOOklo85.03%Insider OwnershipCompanyInsider OwnershipAKROAkero Therapeutics7.07%HEESH&E Equipment Services12.50%OKLOOklo18.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKROAkero Therapeutics3079.99 million74.33 millionOptionableHEESH&E Equipment Services2,38036.67 million32.03 millionOptionableOKLOOklo78147.61 million119.71 millionOptionableAKRO, HEES, and OKLO HeadlinesRecent News About These CompaniesOklo (NYSE:OKLO) Stock Price Up 2.3% - Here's Why1 hour ago | marketbeat.comBetter Energy Stock: Cameco vs. OkloSeptember 4 at 4:05 AM | fool.comOklo Inc Plans Additional Stock Sale Under SEC FilingSeptember 3 at 10:39 PM | msn.comOklo (NYSE:OKLO) Shares Down 2.3% - Here's WhySeptember 3 at 2:44 PM | marketbeat.comJAT Capital Mgmt LP Sells 573,212 Shares of Oklo Inc. $OKLOSeptember 3 at 7:28 AM | marketbeat.comCreativeOne Wealth LLC Buys New Holdings in Oklo Inc. $OKLOSeptember 3 at 4:18 AM | marketbeat.comRaymond James Financial Inc. Increases Stock Holdings in Oklo Inc. $OKLOSeptember 3 at 3:34 AM | marketbeat.comTop 5 September Stock Picks: Market Tailwinds Drive New Momentum (OKLO)...September 2 at 11:53 AM | marketbeat.comOKLO's Fast Reactor Promise: Safe, Clean and Fuel RecyclingSeptember 2 at 9:25 AM | zacks.comTwin Tree Management LP Boosts Holdings in Oklo Inc. $OKLOSeptember 2 at 5:24 AM | marketbeat.comKestra Advisory Services LLC Sells 77,463 Shares of Oklo Inc. $OKLOSeptember 2 at 4:06 AM | marketbeat.com24,185 Shares in Oklo Inc. $OKLO Acquired by Evergreen Capital Management LLCSeptember 1 at 5:38 AM | marketbeat.comOklo (NYSE:OKLO) & Siemens Energy (OTCMKTS:SMNEY) Financial AnalysisSeptember 1 at 3:37 AM | americanbankingnews.comIs Oklo Stock a Buy, Sell, or Hold for September 2025?August 31, 2025 | finance.yahoo.comOMERS ADMINISTRATION Corp Acquires New Position in Oklo Inc. $OKLOAugust 31, 2025 | marketbeat.comOklo Inc. (OKLO) Drops 5% on Profit-TakingAugust 31, 2025 | insidermonkey.comOklo Inc. Stock (OKLO) Opinions on Nuclear Energy AdvancementsAugust 30, 2025 | quiverquant.comQOklo (NYSE:OKLO) Stock Price Down 5% - Time to Sell?August 30, 2025 | marketbeat.comIs Oklo Stock a Buy Now?August 30, 2025 | fool.comOklo (OKLO) Advances With New U.S. Nuclear Regulatory ApprovalAugust 29, 2025 | finance.yahoo.comJim Cramer Says “Buy Oklo”August 29, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025Data Centers Create a Bull Case for These Nuclear 3 StocksBy Gabriel Osorio-Mazilli | August 14, 2025Oklo’s Stock Is Set up for a Correction—Buy It When It BouncesBy Thomas Hughes | August 12, 2025AKRO, HEES, and OKLO Company DescriptionsAkero Therapeutics NASDAQ:AKRO$43.76 -1.86 (-4.07%) As of 03:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.H&E Equipment Services NASDAQ:HEESH&E Equipment Services, Inc. engages in the provision of equipment services, which focus on heavy construction and industrial equipment. It operates through the following segments: Equipment Rentals, Sales of Rental Equipment, Sales of New Equipment, and Parts, Service and Other Revenues. The Equipment Rentals segment focuses on renting construction and industrial equipment. The Sales of Rental Equipment segment is generated primarily from sales from the rental fleet. The Sales of New Equipment segment sells equipment through a professional sales force. The Parts, Service and Other Revenues segment provides parts to the own rental fleet and sells parts for the equipment. The company was founded by Tom Engquist and Frank Head in 1961 and is headquartered in Baton Rouge, LA.Oklo NYSE:OKLO$69.86 -2.37 (-3.28%) As of 03:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is Expected Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Wall Street Punishes Dell's Record Quarter: Why They Are Wrong Ambarella's Earnings Prove Its Edge AI Strategy Is a Winner Taiwan Semiconductor Falls on China News—Buy The Dip? CrowdStrike Tests $412 Support as Options Traders Turn Bullish Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
